Author

P. Nuciforo

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:human· 3 Research Focus:cancer & tumor microenvironment· 2 Assay:ChIP-seq· 2 Research Focus:chromatin & epigenetic regulation· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1

Frequent Co-Authors

G. Serra-Bardenys· 2 shared G. Verde· 2 shared J. Arribas· 2 shared J. Querol· 2 shared L. Pascual-Reguant· 2 shared R. Dienstmann· 2 shared S. Peiró· 2 shared S. Segura-Bayona· 2 shared

Activity by Year

2018-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 43 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

G. Serra-Bardenys

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Evaluation of homologous recombination repair status in metastatic prostate cancer by next-generation sequencing and functional tissue-based immunofluorescence assays

S. Arce-Gallego, P. C. Morgado, L. Delgado-Serrano, S. Simonetti, M. Gonzalez, D. Marmolejo, R. Morales-Barrera, G. Mir, M. E. Semidey, P. R. Lozano, S. Cordoba-Terreros, R. Mast, M. de Albert, J. Planas, M. Cuadras, , J. Mateo

This study evaluates homologous recombination repair status in metastatic prostate cancer using next-generation sequencing and RAD51 immunofluorescence assays, finding strong correlation between genomic and functional HRR loss.

bioRxiv · Jan 28, 2024Cancer Biology

Maintaining oxidized H3 in heterochromatin is required for the oncogenic capacity of triple-negative breast cancer cells

G. Serra-Bardenys, T. V. Tian, E. Blanco, J. Querol, L. Pascual-Reguant, B. Morancho, M. Escorihuela, S. Segura-Bayona, G. Verde, R. Aiese Cigliano, A. Millanes-Romero, C. Jerónimo, P. Nuciforo, S. Simonetti, C. Viaplana, , S. Peiró

This study identifies the role of H3K4ox in maintaining heterochromatin structure in TNBC cells and shows its necessity for oncogenic properties.

bioRxiv · Jan 30, 2020 · PreprintCancer Biology

Reduction of LOXL2-mediated H3K4 oxidation increases chromatin accessibility and promotes chemosensitivity of triple-negative breast cancer cells

J.P. Cebrià-Costa, L. Pascual-Reguant, A. Gonzalez-Perez, G. Serra-Bardenys, J. Querol, M. Cosín, G. Verde, R.A. Cigliano, W. Sanseverino, S. Segura-Bayona, A. Iturbide, D. Andreu, P. Nuciforo, C. Bernado-Morales, V. Rodilla, , S. Peiró

This study shows that reducing LOXL2-mediated H3K4 oxidation decreases chromatin compaction and increases chemosensitivity in triple-negative breast cancer cells.

bioRxiv · Sep 13, 2018 · PreprintCancer Biology